Chicago Post ASH 2022: Session 2: Panel Discussion, Cell Therapy in Multiple Myeloma, and MCL and CAR-T
Our Faculty, Biological Sciences Division
Our Leukemia Physician Team - UChicago Medicine
Chicago Tribune - Year 173 No. 222 (09 Aug 2020) PDF, PDF, Chicago Tribune
7th Annual Updates from ASH 2021: Practice Changing Abstracts
Chicago Post ASH 2022: Session 2: Panel Discussion, Cell Therapy in Multiple Myeloma, and MCL and CAR-T
Chicago Post ASH 2022: Session 2: Panel Discussion, Cell Therapy in Multiple Myeloma, and MCL and CAR-T
Dr. Austin Wesevich, MD โ Chicago, IL
Adam DuVall MD, MPH (@AyaOncologist) / X